Your shopping cart is currently empty

p38-α MAPK-IN-11 (Compound 4C) is a selective blood-brain barrier-penetrable inhibitor of P38α MAPK, with an IC50 of 43 nM. It exhibits minimal inhibitory activity against other MAPK isoforms, such as p38β, p38γ, and p38δ, with IC50 values of > 100 nM, > 100 nM, and 48.6 mM, respectively. In rat models resembling Alzheimer’s disease, p38-α MAPK-IN-11 demonstrates significant neuroprotective and anti-neuroinflammatory effects. This compound is valuable for Alzheimer's disease research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | p38-α MAPK-IN-11 (Compound 4C) is a selective blood-brain barrier-penetrable inhibitor of P38α MAPK, with an IC50 of 43 nM. It exhibits minimal inhibitory activity against other MAPK isoforms, such as p38β, p38γ, and p38δ, with IC50 values of > 100 nM, > 100 nM, and 48.6 mM, respectively. In rat models resembling Alzheimer’s disease, p38-α MAPK-IN-11 demonstrates significant neuroprotective and anti-neuroinflammatory effects. This compound is valuable for Alzheimer's disease research. |
| Targets&IC50 | p38α:43 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.